Elevance Health, Inc.

ELV · Healthcare

$412.34
+2.93% today

What a holder would want to know before buying ELV: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $280.74 · Mar 2026High $426.79 · Jul 2026

Today’s price is 47% above the lowest point of the past year and 3% below the highest.

Over the past year it was cheaper than today on 93% of days and more expensive on 7%. Over the last 10 years: cheaper on 69% of days.

12% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more 3 times in 10 years. The deepest fall was 51%; the longest took 20 months to get back to its peak. 2 of 3 have recovered so far.

It is in one now: 27% below the Sep 2024 peak.

Sep 2024
−51%not back yet
Oct 2022
−24%back in 19 months
Feb 2019
−45%back in 20 months
What you own

Elevance Health, Inc. · Healthcare · Healthcare Plans · a large company worth $89.50B

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate &…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $199.13B in 2025, with $5.66B of profit. Sales grew in 3 of the last 3 years.

Keeps about 2 cents of every dollar of sales as profit.

Is it healthy?
Cash
$37.51B
Debt
$31.04B
Free cash flow / yr
$4.31B

Would need about 7.2 years of free cash flow to repay all its debt.

Is it expensive?

You pay $18 for every $1 of last year’s profit, and $14 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 1.72% a year in dividends at today’s price · next ex-dividend Sep 10.

What others are doing

22 analysts: 15 say buy, 7 hold, 0 sell. Their average 12-month target is $451.48 (range $393.00–$492.00).

Insiders made 2 purchases and 3 sales in the last 6 months.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy ELV with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.